Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Jason Wang | |
| Angel | Jon Brelig | |
| Angel | Carol Gallagher | |
| Angel | James Park | |
| Angel | Ralph Gootee | |
| Angel | Manik Gupta |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Checkmate Pharmaceuticals raised $27M in a Series B round.
The round was announced on 06/01/17.
The round was led by Ben Auspitz.